CNS Drugs

Acknowledgement
pp. 985-987(3)
Author: Adis International Limited,

The Development of Anti-Amyloid Therapy for Alzheimer’s Disease: From Secretase Modulators to Polymerisation Inhibitors
pp. 989-996(8)
Author: Aisen, Paul S.

Night Eating Syndrome: Diagnosis, Epidemiology and Management
pp. 997-1008(12)
Authors: O’Reardon, John P.; Peshek, Andrew; Allison, Kelly C.

Tick-Borne Encephalopathies: Epidemiology, Diagnosis, Treatment and Prevention
pp. 1009-1032(24)
Authors: Günther, Göran; Haglund, Mats

Initial and Long-Term Management of Autoimmune Neuropathies
pp. 1033-1048(16)
Author: Carol Lee Koski,

Effect of Anticholinergics in Preventing Acute Deterioration in Patients Undergoing Abrupt Clozapine Withdrawal
pp. 1049-1055(7)
Authors: Seppälä, Niko; Kovio, Carita; Leinonen, Esa

Ramelteon
pp. 1057-1065(9)
Authors: McGechan, Adam; Wellington, Keri

Ramelteon: A Viewpoint by Matthew W. Johnson and Roland R. Griffiths
pp. 1066-1067(2)
Authors: Johnson, Matthew W.; Griffiths, Rolands R.

Ramelteon: A Viewpoint by Göran Hajak
pp. 1066-1067(2)
Authors: Hajak, Göran

Spotlight on Remifentanil for General Anaesthesia
pp. 1069-1074(6)
Authors: Scott, Lesley J.; Perry, Caroline M.